Andrew B. McGeachie
Sanofi (Australia)(AU)Macquarie University(AU)
Publications by Year
Research Areas
Cellular transport and secretion, Retinal Development and Disorders, Parkinson's Disease Mechanisms and Treatments, Alzheimer's disease research and treatments, Lipid Membrane Structure and Behavior
Most-Cited Works
- → Building a Better Dynasore: The Dyngo Compounds Potently Inhibit Dynamin and Endocytosis(2013)338 cited
- → Inhibition of Dynamin Mediated Endocytosis by the Dynoles—Synthesis and Functional Activity of a Family of Indoles(2009)168 cited
- → Myristyl Trimethyl Ammonium Bromide and Octadecyl Trimethyl Ammonium Bromide Are Surface-Active Small Molecule Dynamin Inhibitors that Block Endocytosis Mediated by Dynamin I or Dynamin II(2007)116 cited
- → TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes(2015)114 cited
- → Mullerian Inhibiting Substance acts as a motor neuron survival factor in vitro(2005)95 cited
- → Extracellular ATP dissociates nonmuscle myosin from P2X7 complex: this dissociation regulates P2X7 pore formation(2009)89 cited
- → Small Molecule Inhibitors of Dynamin I GTPase Activity: Development of Dimeric Tyrphostins(2005)81 cited
- → Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43(2013)75 cited
- → A stabilising influence: Integrins in regulation of synaptic plasticity(2011)70 cited
- → Iminochromene Inhibitors of Dynamins I and II GTPase Activity and Endocytosis(2010)64 cited